EFFECT OF MICROSPHERE SIZE AND FORMULATION FACTORS ON DRUG RELEASE FROM CONTROLLED-RELEASE FUROSEMIDE MICROSPHERES

被引:13
作者
AKBUGA, J
机构
[1] Department of Pharmaceutical Technology Faculty of Pharmacy, University of Marmara, 80200, Nisçlantasçli, Istanbul
关键词
D O I
10.3109/03639049109044266
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Controlled-release furosemide microspheres were prepared with various combinations of Eudragit L: Eudragit RS and Eudragit S: Eudragit RS and release of drug from microspheres containing these polymers in different ratios was studied. A wide range of release rates of drug can obtained by a simple change in the ratio of polymers. An increase in Eudragit RS content of polymer microsphere matrix brought about a decrease in the release rate. On the other hand, the effect of particle size on the drug release rate from furosemide microspheres was also investigated. The effect of microsphere sizes on release rate depends on the type of Eudragit. The decrease in release rates of small microspheres may be due to agglomerate formation. Dissolution data indicated that the release followed Higuchi's matrix model kinetics.
引用
收藏
页码:593 / 607
页数:15
相关论文
共 10 条
[1]  
AKBUGA J, IN PRESS INT J PHARM
[2]  
Baker RW, 1974, CONTROLLED RELEASE B, P15, DOI 10.1007/978-1-4684-7239-4_2
[3]   DISSOLUTION CHARACTERISTICS OF POLYCAPROLACTONE-POLYLACTIDE MICROSPHERES OF CHLORPROMAZINE [J].
CHANG, RK ;
PRICE, JC ;
WHITWORTH, CW .
DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY, 1986, 12 (14) :2355-2380
[4]   CONTROL OF DRUG RELEASE RATE BY USE OF MIXTURES OF POLYCAPROLACTONE AND CELLULOSE-ACETATE BUTYRATE POLYMERS [J].
CHANG, RK ;
PRICE, J ;
WHITWORTH, CW .
DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY, 1987, 13 (06) :1119-1135
[6]  
KAWASHIMA Y, 1986, 4TH P INT C PHARM TE, V2, P161
[7]  
Lehmann K., 1982, ACTA PHARM FENN, V91, P225
[8]  
PAL PR, 1988, 7TH P PHARM TECHN C, V1, P134
[9]   PREPARATION AND EVALUATION OF CONTROLLED RELEASE INDOMETHACIN MICROSPHERES [J].
PONGPAIBUL, Y ;
PRICE, JC ;
WHITWORTH, CW .
DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY, 1984, 10 (10) :1597-1616
[10]  
TOMLINSON E, 1984, PHARM ASPECTS RELEAS, P75